Human Papillomavirus Type 16 E6 Gene Variations in Chinese Population

H. B. Cai,C. C. Chen,X. H. Ding
DOI: https://doi.org/10.1016/j.ejso.2009.07.186
IF: 4.037
2009-01-01
European Journal of Surgical Oncology
Abstract:Objective: To identify genetic variants in the E6 gene of HPV 16 and to examine the association between these variants and cervical cancer development.Methods: Cervical samples were collected from 72 patients with cervical cancer and 72 age-matched control subjects, all from Hubei Province, China. HPV 16 sequence was detected with E6 gene-specific polymerase chain reaction, and variants were identified by DNA sequencing.Results: HPV 16 was detected in 81% of the patients and 43% of control subjects, respectively. The rank orders of incidence of HPV 16 prototype and E6 variants were as follows: D25E (62%), the prototype (17%), E113D (9%), L83V (6%) in case subjects;, the prototype (71%), D25E (23%), L83V/E113D (7%) in control subjects. The odds ratio of HPV 16 E6 variant was higher than that of prototype (RR = 11.73, 95% Cl =4.18-32.94. P=0.0001).Conclusion: The D25 E variant is the most prevalent E6 genomic variant in Hubei, China. The presence of HPV 16 E6 variant in cervical intraepithelial neoplasia (CIN) lesions may serve as a useful predictor of clinical outcome of the disease. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?